Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Paycom Software Inc (PAYC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Paycom Software Inc — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $108.02 (market cap $8.88B), while Paycom Software Inc trades at $245.07 (market cap $10.77B). The key difference: Paycom Software Inc is the larger of the two by market cap, and Paycom Software Inc pays a 0.63% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Paycom Software Inc for 84 Days on average.
| KYMR | PAYC | |
|---|---|---|
Market Cap | $8.88B | $10.77B |
Volume | 1,028,790 | 536,440 |
Sector | Health | Technology |
52-Week High | $127.31 | $240.52 |
52-Week Low | $55.80 | $113.59 |
Typical Hold Time | 0 Days | 84 Days |
Enterprise Value | $8.27B | $11.56B |
Dividend Yield | — | 0.63% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Paycom Software (PAYC) trades at $243.00, up 2.7% with strong technical momentum and bullish moving averages. The company demonstrates robust fundamentals with 10% revenue growth in Q2 2026, 48% EPS growth, and impressive profitability metrics including 83.67% gross margin and 22.78% net margin. Recent earnings beats and raised full-year guidance signal operational strength, while institutional buying activity reflects positive sentiment.
PAYC presents a compelling growth story with strong execution, though current valuation multiples (P/E 25.29, P/S 5.83) appear elevated. Key risks include competitive pressures in payroll software and potential labor market cooling. Analyst consensus shows balanced sentiment with 47% buy ratings but a $211.08 price target below current levels, suggesting cautious optimism amid strong performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Paycom Software Inc
Paycom is a fast-growing provider of payroll and human capital management, or HCM, software primarily targeting clients with 50-10,000 employees in the United States. Paycom was established in 1998 and services about 18,000 clients as of 2021, based on parent company grouping. Alongside its core payroll software, Paycom offers various HCM add-on modules, including time and attendance, talent management, and benefits administration.
Read more on PAYC →
